Novartis Investigative Site — Grand Rapids, Michigan

Novartis Investigative Site is a clinical research site located in Grand Rapids, Michigan, United States 49525.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

Novartis Investigative Site has participated in 9 clinical trials.

Therapeutic areas: Relapsing Remitting Multiple Sclerosis, Macular Degeneration, Choroidal Neovascularization.

Sponsors: Novartis Pharmaceuticals, Novartis, Mylan Inc..

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Novartis Investigative Site?

Novartis Investigative Site has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Novartis Investigative Site conducted?

Novartis Investigative Site has 9 clinical trials on record. Their work covers Relapsing Remitting Multiple Sclerosis, Macular Degeneration, Choroidal Neovascularization.

Is Novartis Investigative Site accredited by Crixeo Health?

Yes — Novartis Investigative Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Novartis Investigative Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.